Amgen Inc. 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 4:18 pm Sale | 2023-01-31 | 13G | Jasper Therapeutics, Inc. JSPR | AMGEN INC AMGN | 100,993 0.900% | -169,007 (-62.60%) | Filing |
| 2021-10-01 5:27 pm Purchase | 2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR | AMGEN INC AMGN | 270,000 7.400% | 270,000 (New Position) | Filing |